Abstract
Early [<sup>18</sup>F]FDG PET/CT response evaluation after a single dose of anti-EGFR therapy as a predictive biomarker for treatment benefit in patients with advanced colorectal cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have